Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 36 | 2024 | 5146 | 1.490 |
Why?
|
Urea | 2 | 2013 | 443 | 0.450 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2013 | 655 | 0.400 |
Why?
|
Morpholines | 1 | 2014 | 581 | 0.370 |
Why?
|
Boronic Acids | 9 | 2014 | 915 | 0.370 |
Why?
|
Oligopeptides | 4 | 2024 | 1187 | 0.370 |
Why?
|
Phosphorylcholine | 1 | 2010 | 153 | 0.330 |
Why?
|
Pyrazines | 9 | 2014 | 1202 | 0.330 |
Why?
|
Pyrazoles | 4 | 2015 | 2009 | 0.320 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2014 | 2057 | 0.290 |
Why?
|
Apoptosis | 15 | 2017 | 9490 | 0.280 |
Why?
|
Osteoblasts | 6 | 2016 | 1143 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 2457 | 0.250 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2014 | 3605 | 0.240 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2017 | 2872 | 0.240 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2024 | 11742 | 0.230 |
Why?
|
Sirolimus | 2 | 2014 | 1533 | 0.230 |
Why?
|
Cell Line, Tumor | 22 | 2015 | 16990 | 0.220 |
Why?
|
Thalidomide | 4 | 2014 | 885 | 0.220 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2013 | 2917 | 0.210 |
Why?
|
Antineoplastic Agents | 9 | 2015 | 13642 | 0.210 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2015 | 424 | 0.200 |
Why?
|
Osteoclasts | 5 | 2014 | 711 | 0.200 |
Why?
|
Dexamethasone | 3 | 2024 | 1948 | 0.200 |
Why?
|
Mice, SCID | 11 | 2016 | 2626 | 0.190 |
Why?
|
Hydroxamic Acids | 2 | 2015 | 481 | 0.180 |
Why?
|
Pyrimidines | 4 | 2015 | 3028 | 0.180 |
Why?
|
Activins | 2 | 2013 | 210 | 0.170 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2015 | 774 | 0.170 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7593 | 0.160 |
Why?
|
Signal Transduction | 8 | 2017 | 23447 | 0.160 |
Why?
|
Bone Marrow Cells | 6 | 2012 | 2417 | 0.160 |
Why?
|
Osteolysis | 2 | 2011 | 275 | 0.160 |
Why?
|
Histone Deacetylases | 2 | 2013 | 720 | 0.150 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2016 | 1651 | 0.140 |
Why?
|
Drug Synergism | 5 | 2015 | 1757 | 0.140 |
Why?
|
Bone Remodeling | 2 | 2011 | 581 | 0.130 |
Why?
|
Decorin | 1 | 2015 | 38 | 0.120 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2015 | 718 | 0.120 |
Why?
|
Mice | 23 | 2016 | 81539 | 0.120 |
Why?
|
Plasmacytoma | 2 | 2014 | 171 | 0.120 |
Why?
|
Cell Proliferation | 9 | 2014 | 10451 | 0.120 |
Why?
|
Casein Kinase Ialpha | 1 | 2014 | 26 | 0.120 |
Why?
|
Enzyme Activation | 5 | 2012 | 3597 | 0.110 |
Why?
|
Chemokine CCL3 | 2 | 2011 | 84 | 0.110 |
Why?
|
Phosphorylation | 4 | 2014 | 8321 | 0.110 |
Why?
|
Cell Survival | 6 | 2015 | 5791 | 0.110 |
Why?
|
Stromal Cells | 7 | 2013 | 1330 | 0.110 |
Why?
|
Antibodies, Neutralizing | 2 | 2013 | 1943 | 0.110 |
Why?
|
Genes, ras | 1 | 2015 | 654 | 0.110 |
Why?
|
Cyclohexanones | 1 | 2012 | 30 | 0.100 |
Why?
|
Down-Regulation | 5 | 2011 | 2919 | 0.100 |
Why?
|
Tumor Microenvironment | 2 | 2016 | 3878 | 0.100 |
Why?
|
Benzamides | 2 | 2015 | 1371 | 0.100 |
Why?
|
Bone Diseases | 1 | 2016 | 418 | 0.100 |
Why?
|
Acrylamides | 1 | 2014 | 260 | 0.100 |
Why?
|
Epoxy Compounds | 1 | 2012 | 137 | 0.100 |
Why?
|
Receptors, CCR1 | 2 | 2011 | 30 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 4 | 2013 | 5672 | 0.100 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2014 | 287 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2016 | 3617 | 0.090 |
Why?
|
MAP Kinase Signaling System | 2 | 2015 | 1486 | 0.090 |
Why?
|
Imidazoles | 3 | 2015 | 1180 | 0.090 |
Why?
|
Plasma Cells | 1 | 2014 | 599 | 0.090 |
Why?
|
Animals | 24 | 2016 | 168475 | 0.090 |
Why?
|
Osteocalcin | 1 | 2011 | 274 | 0.090 |
Why?
|
Calcification, Physiologic | 1 | 2011 | 170 | 0.090 |
Why?
|
Endoribonucleases | 1 | 2012 | 228 | 0.090 |
Why?
|
Benzimidazoles | 2 | 2015 | 858 | 0.090 |
Why?
|
Caspases | 2 | 2010 | 879 | 0.090 |
Why?
|
Neoplasm Transplantation | 4 | 2016 | 2016 | 0.080 |
Why?
|
Flavones | 1 | 2009 | 68 | 0.080 |
Why?
|
Maytansine | 1 | 2009 | 86 | 0.080 |
Why?
|
Cerulenin | 1 | 2008 | 7 | 0.080 |
Why?
|
Prednisolone | 1 | 2009 | 326 | 0.080 |
Why?
|
Syndecan-1 | 1 | 2009 | 163 | 0.080 |
Why?
|
Glycoproteins | 1 | 2016 | 2203 | 0.080 |
Why?
|
Interleukin-6 | 4 | 2012 | 3208 | 0.080 |
Why?
|
Azepines | 1 | 2010 | 329 | 0.070 |
Why?
|
Melphalan | 1 | 2009 | 420 | 0.070 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 411 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2010 | 1935 | 0.070 |
Why?
|
Veterans | 1 | 2021 | 2649 | 0.070 |
Why?
|
Albumins | 1 | 2010 | 575 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1853 | 0.070 |
Why?
|
RNA Splicing | 1 | 2012 | 918 | 0.070 |
Why?
|
Bone Marrow | 2 | 2015 | 2911 | 0.070 |
Why?
|
Cyclin D1 | 1 | 2009 | 451 | 0.070 |
Why?
|
Autophagy | 2 | 2015 | 1327 | 0.070 |
Why?
|
Protease Inhibitors | 1 | 2009 | 754 | 0.060 |
Why?
|
Immunologic Factors | 2 | 2017 | 1590 | 0.060 |
Why?
|
Ascorbic Acid | 1 | 2009 | 655 | 0.060 |
Why?
|
RNA Polymerase II | 1 | 2010 | 539 | 0.060 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2009 | 621 | 0.060 |
Why?
|
Humans | 38 | 2024 | 761596 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2425 | 0.060 |
Why?
|
Diphosphonates | 1 | 2009 | 635 | 0.060 |
Why?
|
Osteogenesis | 1 | 2011 | 1273 | 0.060 |
Why?
|
NF-kappa B | 1 | 2012 | 2490 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2013 | 2048 | 0.050 |
Why?
|
Cell Cycle | 4 | 2014 | 2932 | 0.050 |
Why?
|
Doxorubicin | 3 | 2015 | 2224 | 0.050 |
Why?
|
Tumor Cells, Cultured | 4 | 2012 | 6131 | 0.050 |
Why?
|
Immunoconjugates | 1 | 2009 | 953 | 0.050 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2009 | 1520 | 0.050 |
Why?
|
Piperidines | 1 | 2010 | 1656 | 0.050 |
Why?
|
Blotting, Western | 3 | 2017 | 5035 | 0.050 |
Why?
|
Antioxidants | 1 | 2009 | 1668 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2017 | 1612 | 0.040 |
Why?
|
Cell Lineage | 1 | 2009 | 2557 | 0.040 |
Why?
|
Cell Communication | 1 | 2007 | 1657 | 0.040 |
Why?
|
Bone and Bones | 1 | 2009 | 2568 | 0.040 |
Why?
|
Nanoparticles | 1 | 2010 | 1958 | 0.040 |
Why?
|
Transplantation, Heterologous | 3 | 2012 | 2386 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2011 | 8554 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2010 | 441 | 0.040 |
Why?
|
Cell Differentiation | 5 | 2014 | 11530 | 0.040 |
Why?
|
Disease Progression | 2 | 2014 | 13510 | 0.030 |
Why?
|
Transcription Factors | 2 | 2012 | 12130 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9610 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 303 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 1 | 2019 | 928 | 0.030 |
Why?
|
Phagosomes | 1 | 2015 | 199 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 384 | 0.030 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2014 | 200 | 0.030 |
Why?
|
Interleukin-3 | 1 | 2014 | 425 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2009 | 1334 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1203 | 0.030 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2012 | 68 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2010 | 10194 | 0.030 |
Why?
|
Gene Expression Profiling | 3 | 2014 | 9420 | 0.030 |
Why?
|
Male | 9 | 2024 | 360846 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9177 | 0.030 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2014 | 179 | 0.020 |
Why?
|
Oxazines | 1 | 2014 | 350 | 0.020 |
Why?
|
Benzoquinones | 1 | 2012 | 198 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1827 | 0.020 |
Why?
|
eIF-2 Kinase | 1 | 2012 | 145 | 0.020 |
Why?
|
Retinal Pigment Epithelium | 1 | 2014 | 303 | 0.020 |
Why?
|
Cell Adhesion | 2 | 2009 | 3088 | 0.020 |
Why?
|
Lentivirus | 1 | 2014 | 508 | 0.020 |
Why?
|
Aged | 5 | 2024 | 169310 | 0.020 |
Why?
|
RANK Ligand | 1 | 2012 | 318 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2013 | 456 | 0.020 |
Why?
|
Lactams, Macrocyclic | 1 | 2012 | 318 | 0.020 |
Why?
|
Unfolded Protein Response | 1 | 2012 | 234 | 0.020 |
Why?
|
Bone Resorption | 1 | 2014 | 723 | 0.020 |
Why?
|
Smad2 Protein | 1 | 2010 | 145 | 0.020 |
Why?
|
Cell Line | 2 | 2014 | 15601 | 0.020 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2010 | 178 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2009 | 53 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2011 | 486 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2012 | 1704 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29629 | 0.020 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2010 | 326 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 615 | 0.020 |
Why?
|
Caspase 9 | 1 | 2008 | 185 | 0.020 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2008 | 149 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2014 | 1321 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2012 | 2264 | 0.020 |
Why?
|
Caspase 8 | 1 | 2008 | 190 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2467 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10766 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2010 | 629 | 0.020 |
Why?
|
Genes, fos | 1 | 2007 | 176 | 0.020 |
Why?
|
Cell Fusion | 1 | 2007 | 294 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2012 | 12794 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2011 | 871 | 0.020 |
Why?
|
Drug Evaluation | 1 | 2008 | 641 | 0.020 |
Why?
|
Cell Death | 1 | 2012 | 1679 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10508 | 0.020 |
Why?
|
Actins | 1 | 2014 | 2050 | 0.020 |
Why?
|
Cell Division | 1 | 2013 | 4465 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2015 | 2057 | 0.020 |
Why?
|
Caspase 3 | 1 | 2008 | 731 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2012 | 1844 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2898 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2010 | 1171 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18255 | 0.020 |
Why?
|
Retinoblastoma Protein | 1 | 2009 | 672 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2013 | 18966 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3358 | 0.010 |
Why?
|
Female | 6 | 2024 | 392705 | 0.010 |
Why?
|
Adult | 4 | 2024 | 221210 | 0.010 |
Why?
|
United States | 2 | 2021 | 72340 | 0.010 |
Why?
|
Bone Density Conservation Agents | 1 | 2009 | 795 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8466 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3713 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5440 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2010 | 2201 | 0.010 |
Why?
|
Middle Aged | 3 | 2024 | 220921 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2822 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2418 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11076 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3779 | 0.010 |
Why?
|
Mesenchymal Stem Cells | 1 | 2011 | 1642 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2805 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41495 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2010 | 3801 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 2226 | 0.010 |
Why?
|
Bone Density | 1 | 2009 | 3551 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2014 | 64685 | 0.010 |
Why?
|
Cell Movement | 1 | 2007 | 5205 | 0.010 |
Why?
|
Cytokines | 1 | 2010 | 7396 | 0.010 |
Why?
|
Models, Biological | 1 | 2011 | 9469 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58984 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 5305 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 22174 | 0.010 |
Why?
|
Mutation | 1 | 2014 | 30053 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 39969 | 0.000 |
Why?
|